Caring Brands (CABR) Cash from Financing Activities (2025 - 2026)

Caring Brands' (CABR) quarterly Cash from Financing Activities came in at $395000.0 in Q1 2026, down 87.78% quarter-over-quarter from $3.2 million in Q4 2025.

Caring Brands (CABR) Cash from Financing Activities (2025 - 2026) Analysis & Trends

Caring Brands' Cash from Financing Activities history runs 2 years deep, the most recent figure standing at $395000.0 for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -840.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -494.13 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1.48 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -203.80 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -86.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -65.00 Mn
10 Caring Brands 20.08 Mn 21.84 Mn - 395,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 395,000.00
Mar 31, 2026 395,000.00
Dec 31, 2025 3.23 Mn
Dec 31, 2025 3.23 Mn